Clinical Trials Browser

Phase 2 × Thymoma × Octreotide × Clear all

NCT00003283 2023-06-15

Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma

Phase 2 Completed

Thymoma

NCT00332969 2017-03-31

Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma

Phase 2 Completed

Disease, Neoplasms, Thymoma